Viewing StudyNCT00153803



Ignite Creation Date: 2024-05-05 @ 11:51 AM
Last Modification Date: 2024-10-26 @ 9:15 AM
Study NCT ID: NCT00153803
Status: COMPLETED
Last Update Posted: 2019-09-06
First Post: 2005-09-07

Brief Title: Erlotinib or Placebo Following Chemoradiotherapy ChemoRT in Stage III Non-Small Cell Lung Cancer NSCLC
Sponsor: Dartmouth-Hitchcock Medical Center
Organization: Dartmouth-Hitchcock Medical Center

Conditions & Keywords Data

Conditions:
Name
NSCLC
Carcinoma Non-Small-Cell Lung
Non-small Cell Lung Cancer
Keywords:
Name View
Stage III NSCLC View
Erlotinib View
Tarceva View
Web based View